Latest filing published 30 Jan 2023 for RVL Pharmaceuticals plc.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Sriram Venkataraman: trading record in brief
Sriram Venkataraman is a declared insider at 3 companies; the most frequent names are OptiNose, Inc., Lantheus Holdings, Inc. and RVL Pharmaceuticals plc. In total, 22 filings cover trades dated from 21 November 2016 to 27 January 2023.
On the open market, the record shows 2 purchases worth €17.8M and 12 sales worth €116.7M. Sales outweigh purchases by €98.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 3 share grants.
The record was last updated on 30 January 2023 with a transaction in RVL Pharmaceuticals plc. The last insider purchase was made public on 9 August 2022, 1,552 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sriram Venkataraman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,032,995 shares0Ordinary SharesSEC:0001104659-23-008077:0
- 8,000,000 shares@ US$1.55100.0% of flowOrdinary SharesSEC:0001104659-22-088030:0Canonical exit: 6 Nov 2022 (T+90)
- 4,936,926 sharesOrdinary SharesSEC:0001104659-20-128528:0
- ▲
Same trade as the filing by Avista Capital Partners III GP, L.P., counted once
6M USD37SEC1,250,000 shares@ US$5.00100.0% of flowOrdinary SharesSEC:0001104659-20-004324:0Canonical exit: 12 Apr 2020 (T+90) - 887,722 shares@ US$9.1771.0% of flowCommon StockSEC:0000899243-19-028170:0
- 291,516 shares@ US$9.1723.3% of flowCommon StockSEC:0000899243-19-028170:1
- 70,762 shares@ US$9.175.7% of flowCommon StockSEC:0000899243-19-028170:2
- 2,041,759 shares@ US$20.9246.2% of flowCommon StockSEC:0000899243-18-016384:0
- 670,487 shares@ US$20.9215.2% of flowCommon StockSEC:0000899243-18-016384:1
- 162,754 shares@ US$20.923.7% of flowCommon StockSEC:0000899243-18-016384:2
- 12,077,563 sharesCommon StockSEC:0000899243-17-024502:3
- 3,966,107 sharesCommon StockSEC:0000899243-17-024502:4
- 962,735 sharesCommon StockSEC:0000899243-17-024502:5
- 887,721 shares@ US$16.0015.4% of flowCommon StockSEC:0000899243-17-024502:0
- 291,516 shares@ US$16.005.0% of flowCommon StockSEC:0000899243-17-024502:1
- 70,763 shares@ US$16.001.2% of flowCommon StockSEC:0000899243-17-024502:2
- ▼
Same trade as the filing by Avista Capital Partners GP, LLC, counted once
5M USD30SEC450,722 shares@ US$12.209.2% of flowCommon StockSEC:0000899243-17-008307:1 - ▼
Same trade as the filing by Avista Capital Partners GP, LLC, counted once
10M USD31SEC840,000 shares@ US$12.2017.2% of flowCommon StockSEC:0000899243-17-008307:2 - ▼
Same trade as the filing by Avista Capital Partners GP, LLC, counted once
21M USD33SEC1,709,278 shares@ US$12.2035.0% of flowCommon StockSEC:0000899243-17-008307:0 - ▼
Same trade as the filing by Avista Capital Partners GP, LLC, counted once
3M USD27SEC375,601 shares@ US$9.005.8% of flowCommon StockSEC:0000899243-16-034337:1 - ▼
Same trade as the filing by Avista Capital Partners GP, LLC, counted once
6M USD27SEC700,000 shares@ US$9.0010.8% of flowCommon StockSEC:0000899243-16-034337:2 - ▼
Same trade as the filing by Avista Capital Partners GP, LLC, counted once
13M USD28SEC1,424,399 shares@ US$9.0021.9% of flowCommon StockSEC:0000899243-16-034337:0
22 of 14 declarations
